We are live on ! Find out more
KURA icon

Kura Oncology
KURA

44 hedge funds and large institutions have $101M invested in Kura Oncology in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

26% more funds holding

Funds holding: 35 → 44 (+9)

11% more capital invested

Capital invested by funds: $90.7M → $101M (+$9.83M)

2.3% more ownership

Funds ownership: 48.2% → 50.51% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
44
Holders Change
+9
Holders Change %
+25.71%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
13
Reduced
7
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.06M
2
State Street
State Street
Massachusetts
+$1.36M
3
Morgan Stanley
Morgan Stanley
New York
+$1.29M
4
Northern Trust
Northern Trust
Illinois
+$1.21M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$455K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$5.26M
2
CCP
Clough Capital Partners
Massachusetts
-$726K
3
Goldman Sachs
Goldman Sachs
New York
-$533K
4
Millennium Management
Millennium Management
New York
-$355K
5
Squarepoint
Squarepoint
New York
-$196K
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
26
Oxford Asset Management
United Kingdom
$217K +$212K +23,287 New
PIM
27
Partner Investment Management
California
$212K -$6.32K -694 -3%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$142K +$139K +15,300 New
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$131K +$128K +14,099 New
State of Wisconsin Investment Board
30
State of Wisconsin Investment Board
Wisconsin
$102K +$100K +11,000 New
AIG
31
American International Group
New York
$82K +$80.5K +8,846 New
Citigroup
32
Citigroup
New York
$71K +$4.51K +495 +7%
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$42K -$5.27K -579 -11%
SO
34
STRS Ohio
Ohio
$39K +$38.2K +4,200 New
MOACM
35
Mutual of America Capital Management
New York
$23K +$22.8K +2,500 New
Legal & General Group
36
Legal & General Group
United Kingdom
$20K +$19.2K +2,110 New
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$13.9K +$13.6K +1,495 New
AIP
38
Ameritas Investment Partners
Nebraska
$12K +$11.4K +1,252 New
PAM
39
Panagora Asset Management
Massachusetts
$12K +$11.5K +1,261 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$9K +$291 +32 +4%
TRCT
41
Tower Research Capital (TRC)
New York
$6K +$5.78K +635 New
AWM
42
Avior Wealth Management
Nebraska
$4K +$3.64K +400 New
Goldman Sachs
43
Goldman Sachs
New York
– -$533K -60,530 Closed
Millennium Management
44
Millennium Management
New York
– -$355K -40,382 Closed
Squarepoint
45
Squarepoint
New York
– -$196K -22,318 Closed
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
– -$125K -14,156 Closed
SCM
47
Segantii Capital Management
Hong Kong
– -$120K -13,614 Closed
OC
48
Oppenheimer & Co
New York
– -$110K -12,500 Closed
BCM
49
BlueCrest Capital Management
Jersey
– -$89K -10,150 Closed
Barclays
50
Barclays
United Kingdom
– -$61.8K -6,789 -100%
1
2
3

KURA Hedge Fund Activity: Q2 2017 in Review

44 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2017, worth a combined $101M — up 11% from $90.7M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new KURA positions and 10 closed out — a net gain of 9 holders — while 13 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, adding an estimated $5.06M. The largest seller was EcoR1 Capital, cutting an estimated $5.26M.

  • 44 institutional investors held Kura Oncology (KURA) as of Q2 2017, up from 35 in Q1 2017.
  • Funds reported $101M of Kura Oncology stock for Q2 2017, up 11% quarter-over-quarter.
  • 19 funds opened new Kura Oncology positions in Q2 2017 and 10 closed out, a net change of +9 holders.
  • The largest Kura Oncology buyer in Q2 2017 was BlackRock, an estimated $5.06M added.
  • The largest Kura Oncology seller in Q2 2017 was EcoR1 Capital, an estimated $5.26M sold.

Based on aggregated 13F filings for Q2 2017.